ETON
Eton Pharmaceuticals
$50.17
+$0.17 (+0.34%)Oct 26, 2026
Key metrics
The numbers that frame ETON today
- Market cap
- $1.43B
- P/E (TTM)
- 128.6
- EV / FCF
- 97.5
- Gross margin
- 57.9%
- EV / Sales
- 13.6
- ROIC
- 66.3%
- Div yield
- 0%
- Debt / equity
- 0.6
- 52wk Low
- $14.27
- 52wk High
- $66.37
Growth
Revenue and earnings trend for ETON
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ETON
Is Eton Pharmaceuticals a good buy?
Yes. Eton Pharmaceuticals has excellent quality and excellent momentum. Both signals support the setup. Growth looks excellent, which supports the long-term business case. We think Eton Pharmaceuticals is selling at a high price, which cuts against the buy case.
What is the market capitalization of ETON?
Eton Pharmaceuticals's market capitalization is $1.43B.
What is the P/E (TTM) ratio for ETON stock?
Eton Pharmaceuticals's P/E (TTM) ratio is 128.6, based on trailing earnings.
What is the 52-week high for ETON stock?
The 52-week high for Eton Pharmaceuticals is $66.37. The current close of $50.17 is 24.4% below that high.
What is the 52-week low for ETON stock?
The 52-week low for Eton Pharmaceuticals is $14.27. The current close of $50.17 is 251.6% above that low.
Does ETON stock pay dividends?
Eton Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ETON?
Eton Pharmaceuticals's Debt / Equity ratio is 0.62.